Entourage Health Corp.
ETRGF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $40,713 | $40,892 | $42,272 | $29,434 |
| % Growth | -0.4% | -3.3% | 43.6% | – |
| Cost of Goods Sold | $37,005 | $60,783 | $53,987 | $53,640 |
| Gross Profit | $3,708 | -$19,891 | -$11,715 | -$24,206 |
| % Margin | 9.1% | -48.6% | -27.7% | -82.2% |
| R&D Expenses | $0 | $202 | $397 | $834 |
| G&A Expenses | $19,711 | $24,095 | $25,733 | $26,708 |
| SG&A Expenses | $25,133 | $29,635 | $29,192 | $28,482 |
| Sales & Mktg Exp. | $5,422 | $5,540 | $3,459 | $1,774 |
| Other Operating Expenses | -$48 | $2,302 | $435 | -$2,063 |
| Operating Expenses | $25,086 | $32,139 | $30,024 | $27,254 |
| Operating Income | -$21,378 | -$52,242 | -$35,895 | -$47,414 |
| % Margin | -52.5% | -127.8% | -84.9% | -161.1% |
| Other Income/Exp. Net | -$24,790 | -$71,639 | -$37,196 | -$38,148 |
| Pre-Tax Income | -$46,168 | -$123,146 | -$78,935 | -$89,607 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$46,168 | -$176,862 | -$95,669 | -$99,494 |
| % Margin | -113.4% | -432.5% | -226.3% | -338% |
| EPS | -0.15 | -0.58 | -0.38 | -0.48 |
| % Growth | 74.1% | -52.6% | 20.8% | – |
| EPS Diluted | -0.15 | -0.58 | -0.38 | -0.48 |
| Weighted Avg Shares Out | 307,849 | 305,061 | 249,013 | 208,047 |
| Weighted Avg Shares Out Dil | 307,849 | 305,061 | 249,013 | 208,047 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $10,774 | $66 |
| Interest Expense | $24,387 | $17,190 | $10,774 | $5,907 |
| Depreciation & Amortization | $384 | $5,852 | $6,753 | $2,153 |
| EBITDA | -$21,397 | -$46,389 | -$29,142 | -$45,260 |
| % Margin | -52.6% | -113.4% | -68.9% | -153.8% |